Detail akcie Perrigo online

Business Summary: Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Perrigo Company PLC revenues decreased 3% to $4.25B. Net loss before extraordinary items increased from $160.7M to $1.4B. Revenues reflect CSCA segment decrease of 4% to $2.59B, CSCI segment decrease of 1% to $1.67B, United States segment decrease of 4% to $2.54B, All other countries segment decrease of 19% to $96.7M. Higher net loss reflects CSCA segment loss totaling $669M vs. income of $269.9M.